Accessibility Menu

Takeda Pharmaceutical(FRA) TKD

Market Cap€49.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€30.69
-0.71%
-0.22Today

Takeda Pharmaceutical Financials at a Glance

Market Cap

€49.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€25.65K

Net Income (TTM)

-€885.39

EPS (TTM)

-€0.57

P/E Ratio

-55.49

Dividend

€1.12

Beta (Volatility)

-0.01 (Low)

Price

€30.69

Volume

0

Open

€30.93

Previous Close

€30.69

Daily Range

€30.69 - €30.93

52-Week Range

€22.45 - €32.02

Estimated Earnings Date

N/A

TKD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Takeda Pharmaceutical

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Industry

Pharmaceuticals

Sector

Health Care

Employees

47,029

CEO

Julie So-Young Kim

Website

www.takeda.com

TKD Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-2.19%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.80%

Dividend Yield

3.60%

Payout Ratio

N/A

Stock Overview

Market Cap

€49.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.59B

Volume

0

Avg. Volume

194.303

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Takeda Pharmaceutical Performance Analysis

Takeda Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31EUR 28,581,566,8554.5%
20242024-03-31EUR 27,230,531,553-4.7%
20252025-03-31EUR 27,993,583,9982.8%
20262026-03-31EUR 25,804,423,575-7.8%
Takeda Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31EUR 1.4328.2%
20242024-03-31EUR 0.58-59.4%
20252025-03-31EUR 0.41-29.4%
20262026-03-31EUR -0.55N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€6.58K

+1.0%

Gross Profit

€3.79K

+1.1%

Gross Margin

57.57%

+1.1%

Market Cap

€49.56BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.93

N/A

Employees

47,029

N/A

Net Income

€611.26

+0.8%

EBITDA

€2.22K

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€29.07K

+1.5%

Total Debt

€26.59K

+1.0%

Accounts Receivable

€5.01K

+1.3%

Inventory

€7.79K

+1.1%

Long Term Debt

€23.79K

+1.0%

Short Term Debt

€2.80K

+1.3%

Return on Assets

-1.06%

-1.1%

Return on Invested Capital

1.24%

+0.5%

Free Cash Flow

€341.11

+0.4%

Operating Cash Flow

€631.54

+0.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About TKD

What is the current price of Takeda Pharmaceutical?

Takeda Pharmaceutical is trading at €30.69 per share.

What is the 52-week range for Takeda Pharmaceutical?

Over the past 52 weeks, Takeda Pharmaceutical has traded between €22.45 and €32.02.

How much debt does Takeda Pharmaceutical have?

As of the most recent reporting period, Takeda Pharmaceutical reported total debt of €26.59B.

How much cash does Takeda Pharmaceutical have on hand?

Takeda Pharmaceutical reported €2.48B in cash and cash equivalents in its most recent financial results.

What is Takeda Pharmaceutical’s dividend yield?

Takeda Pharmaceutical currently has a dividend yield of 3.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services